Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
BofA double downgrades Hims & Hers
Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
Shares of Hims & Hers slid after Amazon.com said it would offer cheap treatments for concerns like hair loss, skin care and erectile dysfunction, directly competing with the telehealth startup. Amazon on Thursday launched the treatments through its One Medical telehealth service,
Hims & Hers drops 22% on Amazon competition concerns (update)
Hims & Hers (HIMS) fell 22% after Amazon (AMZN) announced it was entering the hair loss and erectile dysfunction treatment markets through its telehealth unit. Read more here.
BofA double downgrades Hims & Hers on Amazon competition
BofA downgraded Hims & Hers (HIMS) to Underperform from Buy with a price target of $18, down from $32. Amazon (AMZN) launched a cash-pay
Amazon One Medical launches service to compete with Hims & Hers
The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five conditions including erectile dysfunction and men’s hair loss.
Hims & Hers cut to underperform by BoA over Amazon competition
BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and erectile dysfunction treatment markets. Read more here.
Hold Rating for Hims & Hers Health Amidst Competitive Pressure from Amazon’s Telehealth Services
Citi analyst Daniel Grosslight has maintained their neutral stance on HIMS stock, giving a Hold rating on November 6. Daniel
Amazon One Medical rolls out telehealth treatment services in competition with Ro, Hims & Hers
Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care. | Amazon One Medical is rolling out a new service to provide Prime members access to clinical treatments for common health and lifestyle conditions like men's hair loss and anti-aging skin care.
Hims & Hers stock falls as Amazon launches Telehealth offering
Shares of Hims & Hers Health, Inc. (HIMS) dropped over 15% Thursday following Amazon’s announcement of new telehealth treatment options aimed at providing low-cost care for a range of health and beauty concerns,
Hims & Hers drops 17% as Amazon rolls out expanded telehealth service
Shares of telehealth services provider Hims & Hers (NYSE:HIMS) fell 17% in morning trading Thursday after Amazon (NASDAQ:AMZN) announced it was launching an expanded pay-per-visit telehealth service,
13h
Amazon's push into telehealth knocks shares of Hims & Hers
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...
14h
Hims & Hers Health Stock Is Tumbling Thursday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...
5h
on MSN
These Stocks Moved the Most Today: Walt Disney, Super Micro, Cisco, ASML, JD.com, Tapestry, Intuitive Machines, Hims & Hers, and More
Walt Disney’s earnings beat Wall Street estimates, Super Micro Computer extends losses, and Cisco posts fiscal first-quarter ...
Becker's Hospital Review
6h
Hims & Hers launches GLP-1 tracker amid shortages
Hims & Hers introduced a new tracker to monitor shortages of GLP-1 weight loss and diabetes drugs, responding to the FDA's decision to end the compounded versions, Yahoo Finance reported Nov. 13.
AOL
1d
What's Going On With Hims & Hers Health Stock On Wednesday?
Health and wellness platform
Hims
&
Hers
Health, Inc. (NYSE:
HIMS
), which has gained traction for its obesity-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Amazon
Homs
Feedback